A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2011
At a glance
- Drugs Pioglitazone; Rosiglitazone
- Indications Multiple sclerosis; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Solvay Pharmaceuticals
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 20 Mar 2010 New trial record